Net sales and order intake declined year-over-year, but cost reductions improved EBITDA and margins. Major new orders in North America and a strong AMR pipeline signal potential for transformative growth, with a strategic focus on the U.S. market.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.